Anti-microbial/Anti-fungal Tests Market
Market Insights on Anti-microbial/Anti-fungal Tests covering sales outlook, demand forecast & up-to-date key trends
Anti-microbial/Anti-fungal Tests Market By Test Types (Molecular Based Tests, Phenotypic Resistance Tests, Complex Test Panels, Mass Spectrometry, Rapid Diagnostic Tests), End User (Hospitals, Ambulatory Surgical Centers, Clinics, Community Health Centers), Type (Antimicrobial Resistance, Microbial Infection) & Region - Forecast 2017 - 2027
Local Governments Entering into Partnerships with Manufacturers in Anti-microbial/Anti-fungal Tests Market
Government partnerships and tendering between diagnostic kit manufacturers is poised to provide manufacturers with substantial long-term opportunities in the anti-microbial/ anti-fungal tests market.
Governments in Latin American and Asian countries are working overtime to eradicate highly infectious diseases by providing free medication and diagnostic tests to their underprivileged citizens through government-backed programs. In order to achieve these objectives, local authorities need a constant supply of diagnostic kits and manufacture tendering or partnerships are the best solution to this.
Partnership / tendering benefits manufacturers as it provides them with a stable revenue stream for a specific period of time. Emerging economies such as India and Brazil have favourable opportunities for tendering and this is expected to boost the anti-microbial/ anti-fungal tests market over the forecast period.
Let us know your requirement to get
100% FREE customization
Companies Strengthening Distribution Channels to Target All End Users in Anti-microbial/Anti-fungal Tests Market
At present, companies in the anti-microbial/ anti-fungal tests market are investing in their distribution networks to increase their sales in untapped markets. An effective way to do so is through strategic partnerships and alliances with local suppliers. These partnerships have proven to be critically important to manufacturers because they provide an edge over the competition and allow companies to introduce their products into niche markets, increasing their user base.
Hospitals are predicted to be the largest end-user in the global anti-microbial/ anti-fungal tests market for the foreseeable future and should push past US$ 1.2 billion by end 2027.
Lack of Innovation Culture a Challenge to Overcome in the Anti-microbial/Anti-Fungal Tests Market
Healthcare providers and medical personnel in general tend to be risk averse and extremely hesitant to change any policies or procedures. There have been several instances in the field of in-vitro diagnostics where physicians have been resistant to change if the impending innovation is likely to reduce the organizational income stream. The management and organization of diagnostic services can further exacerbate this problem.
This constraint is felt even more acutely in emerging economies where innovations performed and maintained by well-funded labs do not work in resource-starved healthcare facilities in far-flung rural areas. Therefore, companies would do well to focus on the hospital segment of the APEJ anti-microbial/ anti-fungal tests market as it is anticipated to push past US$ 250 million in 2027.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystQuality Education and Training Need of the Hour in the Anti-microbial/Anti-fungal Tests Market
For a seamless transition of molecular diagnostics from a lab to a clinic, extensive optimization is required to interpret the results accurately. Diagnostic and clinical labs need highly skilled professionals who are experts in the medical and healthcare field. Unfortunately, limited resources in emerging economies mean that they can allocate only a sliver of public funds to clinical labs and an even smaller percentage of this to quality assurance.
Well-trained personnel are absolutely essential and are in short supply in the 21st century. A WHO report states that Sub-Saharan Africa has an acute healthcare crisis with only 168 medical schools in 47 countries.
In Sub-Saharan Africa, 11 countries do not have a single medical school while 24 have only one. Although hospitals are the largest end-user in MEA anti-microbial/ anti-fungal tests market, the reference laboratory segment is projected to witness a higher CAGR of 5.6% from 2017 to 2027.
Anti-Microbial/Anti-Fungal Tests Market Taxonomy
Test Types:
- Molecular Based Tests
- PCR Test
- DNA Microarray
- Phenotypic Resistance Tests
- Complex Test Panels
- Mass Spectrometry
- Rapid Diagnostic Tests
- E-Test Antibiotic/Antifungal Strips
- Biosensor Platforms
End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Community Health Centers
- Reference Laboratories
Type:
- Antimicrobial Resistance
- Methicillin-Resistant Staphylococcus Aureus
- Vancomycin-Resistant Enterococcus
- Multi-Drug-Resistant Mycobacterium tuberculosis
- Carbapenem-Resistant Enterobacteriaceae gut bacteria
- Microbial Infection
- Antifungal Resistance
- Candida infections
- Aspergillus infection
- Fusariosis
- Others
- Fungal Infection
Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific excluding Japan
- Japan
- Middle East and Africa
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Frequently Asked Questions
The global anti-microbial/anti-fungal tests market is expected to garner US$ 6.52 Billion during the forecast period
The global anti-microbial/anti-fungal tests market is estimated to expand at a CAGR of 6.42% during the assessment period
The eminent players in the global anti-microbial/anti-fungal tests market are Becton, Dickinson and Company, Flinn Scientific, CONDALAB, and Accelerate Diagnostics, among others.
Table of Content
1. Executive Summary
1.1. Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Anti-Microbial/Anti-Fungal Tests Market View Point Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Key Regulations
4. North America Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
4.4.1. U.S.
4.4.2. Canada
4.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
4.5.1. Molecular Based Tests
4.5.1.1. PCR Test
4.5.1.2. DNA Microarray
4.5.2. Phenotypic Resistance Tests
4.5.3. Complex Test Panels
4.5.4. Mass Spectrometry
4.5.5. Rapid Diagnostic Tests
4.5.5.1. E-Test Antibiotic/Antifungal Strips
4.5.5.2. Biosensor Platforms
4.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
4.6.1. Molecular Based Tests
4.6.1.1. PCR Test
4.6.1.2. DNA Microarray
4.6.2. Phenotypic Resistance Tests
4.6.3. Complex Test Panels
4.6.4. Mass Spectrometry
4.6.5. Rapid Diagnostic Tests
4.6.5.1. E-Test Antibiotic/Antifungal Strips
4.6.5.2. Biosensor Platforms
4.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
4.7.1. Anti-microbial Resistance
4.7.2. Microbial Infection
4.7.3. Anti-fungal Resistance
4.7.4. Fungal Infection
4.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
4.8.1. Anti-microbial Resistance
4.8.2. Microbial Infection
4.8.3. Anti-fungal Resistance
4.8.4. Fungal Infection
4.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
4.9.1. Hospitals
4.9.2. Ambulatory Surgical Centers
4.9.3. Clinics
4.9.4. Community Health Centers
4.9.5. Reference Laboratories
4.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
4.10.1. Hospitals
4.10.2. Ambulatory Surgical Centers
4.10.3. Clinics
4.10.4. Community Health Centers
4.10.5. Reference Laboratories
4.11. Market Attractiveness Analysis
4.11.1. By Country
4.11.2. By Test Type
4.11.3. By Infection Type
4.11.4. By End User
4.12. Intensity Mapping
5. Latin America Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Regional Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Rest of Latin America
5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Rest of Latin America
5.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
5.5.1. Molecular Based Tests
5.5.1.1. PCR Test
5.5.1.2. DNA Microarray
5.5.2. Phenotypic Resistance Tests
5.5.3. Complex Test Panels
5.5.4. Mass Spectrometry
5.5.5. Rapid Diagnostic Tests
5.5.5.1. E-Test Antibiotic/Antifungal Strips
5.5.5.2. Biosensor Platforms
5.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
5.6.1. Molecular Based Tests
5.6.1.1. PCR Test
5.6.1.2. DNA Microarray
5.6.2. Phenotypic Resistance Tests
5.6.3. Complex Test Panels
5.6.4. Mass Spectrometry
5.6.5. Rapid Diagnostic Tests
5.6.5.1. E-Test Antibiotic/Antifungal Strips
5.6.5.2. Biosensor Platforms
5.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
5.7.1. Anti-microbial Resistance
5.7.2. Microbial Infection
5.7.3. Anti-fungal Resistance
5.7.4. Fungal Infection
5.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
5.8.1. Anti-microbial Resistance
5.8.2. Microbial Infection
5.8.3. Anti-fungal Resistance
5.8.4. Fungal Infection
5.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
5.9.1. Hospitals
5.9.2. Ambulatory Surgical Centers
5.9.3. Clinics
5.9.4. Community Health Centers
5.9.5. Reference Laboratories
5.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
5.10.1. Hospitals
5.10.2. Ambulatory Surgical Centers
5.10.3. Clinics
5.10.4. Community Health Centers
5.10.5. Reference Laboratories
5.11. Market Attractiveness Analysis
5.11.1. By Country
5.11.2. By Test Type
5.11.3. By Infection Type
5.11.4. By End User
5.12. Intensity Mapping
6. Western Europe Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Regional Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
6.3.1. Germany
6.3.2. United Kingom
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Nordic Region
6.3.7. Rest of Western Europe
6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
6.4.1. Germany
6.4.2. United Kingom
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.4.6. Nordic Region
6.4.7. Rest of Western Europe
6.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
6.5.1. Molecular Based Tests
6.5.1.1. PCR Test
6.5.1.2. DNA Microarray
6.5.2. Phenotypic Resistance Tests
6.5.3. Complex Test Panels
6.5.4. Mass Spectrometry
6.5.5. Rapid Diagnostic Tests
6.5.5.1. E-Test Antibiotic/Antifungal Strips
6.5.5.2. Biosensor Platforms
6.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
6.6.1. Molecular Based Tests
6.6.1.1. PCR Test
6.6.1.2. DNA Microarray
6.6.2. Phenotypic Resistance Tests
6.6.3. Complex Test Panels
6.6.4. Mass Spectrometry
6.6.5. Rapid Diagnostic Tests
6.6.5.1. E-Test Antibiotic/Antifungal Strips
6.6.5.2. Biosensor Platforms
6.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
6.7.1. Anti-microbial Resistance
6.7.2. Microbial Infection
6.7.3. Anti-fungal Resistance
6.7.4. Fungal Infection
6.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
6.8.1. Anti-microbial Resistance
6.8.2. Microbial Infection
6.8.3. Anti-fungal Resistance
6.8.4. Fungal Infection
6.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
6.9.1. Hospitals
6.9.2. Ambulatory Surgical Centers
6.9.3. Clinics
6.9.4. Community Health Centers
6.9.5. Reference Laboratories
6.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
6.10.1. Hospitals
6.10.2. Ambulatory Surgical Centers
6.10.3. Clinics
6.10.4. Community Health Centers
6.10.5. Reference Laboratories
6.11. Market Attractiveness Analysis
6.11.1. By Country
6.11.2. By Test Type
6.11.3. By Infection Type
6.11.4. By End User
6.12. Intensity Mapping
7. Eastern Europe Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Regional Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Trends
7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
7.4.1. Russia
7.4.2. Poland
7.4.3. Rest of Eastern Europe
7.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
7.5.1. Molecular Based Tests
7.5.1.1. PCR Test
7.5.1.2. DNA Microarray
7.5.2. Phenotypic Resistance Tests
7.5.3. Complex Test Panels
7.5.4. Mass Spectrometry
7.5.5. Rapid Diagnostic Tests
7.5.5.1. E-Test Antibiotic/Antifungal Strips
7.5.5.2. Biosensor Platforms
7.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
7.6.1. Molecular Based Tests
7.6.1.1. PCR Test
7.6.1.2. DNA Microarray
7.6.2. Phenotypic Resistance Tests
7.6.3. Complex Test Panels
7.6.4. Mass Spectrometry
7.6.5. Rapid Diagnostic Tests
7.6.5.1. E-Test Antibiotic/Antifungal Strips
7.6.5.2. Biosensor Platforms
7.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
7.7.1. Anti-microbial Resistance
7.7.2. Microbial Infection
7.7.3. Anti-fungal Resistance
7.7.4. Fungal Infection
7.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
7.8.1. Anti-microbial Resistance
7.8.2. Microbial Infection
7.8.3. Anti-fungal Resistance
7.8.4. Fungal Infection
7.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
7.9.1. Hospitals
7.9.2. Ambulatory Surgical Centers
7.9.3. Clinics
7.9.4. Community Health Centers
7.9.5. Reference Laboratories
7.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
7.10.1. Hospitals
7.10.2. Ambulatory Surgical Centers
7.10.3. Clinics
7.10.4. Community Health Centers
7.10.5. Reference Laboratories
7.11. Market Attractiveness Analysis
7.11.1. By Country
7.11.2. By Test Type
7.11.3. By Infection Type
7.11.4. By End User
7.12. Intensity Mapping
8. Asia Pacific excluding Japan Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.3.1. China
8.3.2. India
8.3.3. Australia and New Zealand
8.3.4. ASEAN
8.3.5. Rest of Asia Pacific excluding Japan
8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
8.4.1. China
8.4.2. India
8.4.3. Australia and New Zealand
8.4.4. ASEAN
8.4.5. Rest of Asia Pacific excluding Japan
8.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
8.5.1. Molecular Based Tests
8.5.1.1. PCR Test
8.5.1.2. DNA Microarray
8.5.2. Phenotypic Resistance Tests
8.5.3. Complex Test Panels
8.5.4. Mass Spectrometry
8.5.5. Rapid Diagnostic Tests
8.5.5.1. E-Test Antibiotic/Antifungal Strips
8.5.5.2. Biosensor Platforms
8.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
8.6.1. Molecular Based Tests
8.6.1.1. PCR Test
8.6.1.2. DNA Microarray
8.6.2. Phenotypic Resistance Tests
8.6.3. Complex Test Panels
8.6.4. Mass Spectrometry
8.6.5. Rapid Diagnostic Tests
8.6.5.1. E-Test Antibiotic/Antifungal Strips
8.6.5.2. Biosensor Platforms
8.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
8.7.1. Anti-microbial Resistance
8.7.2. Microbial Infection
8.7.3. Anti-fungal Resistance
8.7.4. Fungal Infection
8.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
8.8.1. Anti-microbial Resistance
8.8.2. Microbial Infection
8.8.3. Anti-fungal Resistance
8.8.4. Fungal Infection
8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
8.9.1. Hospitals
8.9.2. Ambulatory Surgical Centers
8.9.3. Clinics
8.9.4. Community Health Centers
8.9.5. Reference Laboratories
8.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
8.10.1. Hospitals
8.10.2. Ambulatory Surgical Centers
8.10.3. Clinics
8.10.4. Community Health Centers
8.10.5. Reference Laboratories
8.11. Market Attractiveness Analysis
8.11.1. By Country
8.11.2. By Test Type
8.11.3. By Infection Type
8.11.4. By End User
8.12. Intensity Mapping
9. Japan Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
9.1. Introduction
9.2. Regional Market Dynamics
9.2.1. Drivers
9.2.2. Restraints
9.2.3. Trends
9.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
9.3.1. Molecular Based Tests
9.3.1.1. PCR Test
9.3.1.2. DNA Microarray
9.3.2. Phenotypic Resistance Tests
9.3.3. Complex Test Panels
9.3.4. Mass Spectrometry
9.3.5. Rapid Diagnostic Tests
9.3.5.1. E-Test Antibiotic/Antifungal Strips
9.3.5.2. Biosensor Platforms
9.4. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
9.4.1. Molecular Based Tests
9.4.1.1. PCR Test
9.4.1.2. DNA Microarray
9.4.2. Phenotypic Resistance Tests
9.4.3. Complex Test Panels
9.4.4. Mass Spectrometry
9.4.5. Rapid Diagnostic Tests
9.4.5.1. E-Test Antibiotic/Antifungal Strips
9.4.5.2. Biosensor Platforms
9.5. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
9.5.1. Anti-microbial Resistance
9.5.2. Microbial Infection
9.5.3. Anti-fungal Resistance
9.5.4. Fungal Infection
9.6. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
9.6.1. Anti-microbial Resistance
9.6.2. Microbial Infection
9.6.3. Anti-fungal Resistance
9.6.4. Fungal Infection
9.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
9.7.1. Hospitals
9.7.2. Ambulatory Surgical Centers
9.7.3. Clinics
9.7.4. Community Health Centers
9.7.5. Reference Laboratories
9.8. Market Size (US$ Mn) Forecast By End User, 2017–2027
9.8.1. Hospitals
9.8.2. Ambulatory Surgical Centers
9.8.3. Clinics
9.8.4. Community Health Centers
9.8.5. Reference Laboratories
9.9. Market Attractiveness Analysis
9.9.1. By Test Type
9.9.2. By Infection Type
9.9.3. By End User
9.10. Intensity Mapping
10. Middle East & Africa Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027
10.1. Introduction
10.2. Regional Market Dynamics
10.2.1. Drivers
10.2.2. Restraints
10.2.3. Trends
10.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of Middle East and Africa
10.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of Middle East and Africa
10.5. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
10.5.1. Molecular Based Tests
10.5.1.1. PCR Test
10.5.1.2. DNA Microarray
10.5.2. Phenotypic Resistance Tests
10.5.3. Complex Test Panels
10.5.4. Mass Spectrometry
10.5.5. Rapid Diagnostic Tests
10.5.5.1. E-Test Antibiotic/Antifungal Strips
10.5.5.2. Biosensor Platforms
10.6. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
10.6.1. Molecular Based Tests
10.6.1.1. PCR Test
10.6.1.2. DNA Microarray
10.6.2. Phenotypic Resistance Tests
10.6.3. Complex Test Panels
10.6.4. Mass Spectrometry
10.6.5. Rapid Diagnostic Tests
10.6.5.1. E-Test Antibiotic/Antifungal Strips
10.6.5.2. Biosensor Platforms
10.7. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
10.7.1. Anti-microbial Resistance
10.7.2. Microbial Infection
10.7.3. Anti-fungal Resistance
10.7.4. Fungal Infection
10.8. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
10.8.1. Anti-microbial Resistance
10.8.2. Microbial Infection
10.8.3. Anti-fungal Resistance
10.8.4. Fungal Infection
10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
10.9.1. Hospitals
10.9.2. Ambulatory Surgical Centers
10.9.3. Clinics
10.9.4. Community Health Centers
10.9.5. Reference Laboratories
10.10. Market Size (US$ Mn) Forecast By End User, 2017–2027
10.10.1. Hospitals
10.10.2. Ambulatory Surgical Centers
10.10.3. Clinics
10.10.4. Community Health Centers
10.10.5. Reference Laboratories
10.11. Market Attractiveness Analysis
10.11.1. By Country
10.11.2. By Test Type
10.11.3. By Infection Type
10.11.4. By End User
10.12. Intensity Mapping
11. Forecast Factors: Relevance and Impact
12. Competition Landscape
12.1. Market Structure
12.2. Competition Dashboard
12.3. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
12.3.1. Abbott Laboratories
12.3.2. bioMérieux SA
12.3.3. Bio-Rad Laboratories Inc.
12.3.4. Bruker Corporation
12.3.5. Danaher Corporation
12.3.6. Erba Mannheim
12.3.7. F. Hoffmann-La Roche AG
12.3.8. Luminex Corporation
12.3.9. Meridian Bioscience Inc.
12.3.10. Norgen Biotek Corp.
12.3.11. Omega Diagnostics Group Plc.
12.3.12. Qiagen N.V.
12.3.13. Quidel Corporation
12.3.14. Thermo Fisher Scientific Inc.
13. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027, By Region
13.1. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
13.1.1. North America
13.1.2. Latin America
13.1.3. Western Europe
13.1.4. Eastern Europe
13.1.5. Asia Pacific excluding Japan
13.1.6. Japan
13.1.7. Middle East & Africa
13.2. Market Size (US$ Mn) Forecast By Region, 2017–2027
13.2.1. North America
13.2.2. Latin America
13.2.3. Western Europe
13.2.4. Eastern Europe
13.2.5. Asia Pacific excluding Japan
13.2.6. Japan
13.2.7. Middle East & Africa
13.3. Market Attractiveness Analysis By Region
14. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027, By Test Type
14.1. Historical Market Size (US$ Mn) and Volume Trend Analysis By Test Type, 2012–2016
14.1.1. Molecular Based Tests
14.1.1.1. PCR Test
14.1.1.2. DNA Microarray
14.1.2. Phenotypic Resistance Tests
14.1.3. Complex Test Panels
14.1.4. Mass Spectrometry
14.1.5. Rapid Diagnostic Tests
14.1.5.1. E-Test Antibiotic/Antifungal Strips
14.1.5.2. Biosensor Platforms
14.2. Market Size (US$ Mn) and Volume Forecast By Test Type, 2017–2027
14.2.1. Molecular Based Tests
14.2.1.1. PCR Test
14.2.1.2. DNA Microarray
14.2.2. Phenotypic Resistance Tests
14.2.3. Complex Test Panels
14.2.4. Mass Spectrometry
14.2.5. Rapid Diagnostic Tests
14.2.5.1. E-Test Antibiotic/Antifungal Strips
14.2.5.2. Biosensor Platforms
14.3. Market Attractiveness Analysis By Test Type
15. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2015 and Forecast 2017–2027, By Infection Type
15.1. Historical Market Size (US$ Mn) Trend Analysis By Infection Type, 2012–2016
15.1.1. Anti-microbial Resistance
15.1.2. Microbial Infection
15.1.3. Anti-fungal Resistance
15.1.4. Fungal Infection
15.2. Market Size (US$ Mn) Forecast By Infection Type, 2017–2027
15.2.1. Anti-microbial Resistance
15.2.2. Microbial Infection
15.2.3. Anti-fungal Resistance
15.2.4. Fungal Infection
15.3. Market Attractiveness Analysis By Infection Type
16. Global Anti-Microbial/Anti-Fungal Tests Market Analysis 2012–2016 and Forecast 2017–2027, By End User
16.1. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
16.1.1. Hospitals
16.1.2. Ambulatory Surgical Centers
16.1.3. Clinics
16.1.4. Community Health Centers
16.1.5. Reference Laboratories
16.2. Market Size (US$ Mn) Forecast By End User, 2017–2027
16.2.1. Hospitals
16.2.2. Ambulatory Surgical Centers
16.2.3. Clinics
16.2.4. Community Health Centers
16.2.5. Reference Laboratories
16.3.Market Attractiveness Analysis By End User
17. Assumptions and Acronyms Used
18. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 02: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type
Table 03: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type
Table 04: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 05: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 06: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type
Table 07: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type
Table 08: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 09: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 10: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type
Table 11: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type
Table 12: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 13: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 14: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type
Table 15: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type
Table 16: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 17: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 18: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type
Table 19: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type
Table 20: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 21: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type
Table 22: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type
Table 23: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 24: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country
Table 25: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type
Table 26: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type
Table 27: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Table 28: Global Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Region
Table 29: Global Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Test Type
Table 30: Global Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Infection Type
Table 31: Global Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Anti-microbial/Anti-fungal Tests Market Revenue Share by Test Type, 2017E & 2027F
Figure 2: Anti-microbial/Anti-fungal Tests Market Revenue Share by Infection Type, 2017E & 2027F
Figure 3: Anti-microbial/Anti-fungal Tests Market Revenue Share by End User, 2017E & 2027F
Figure 4: North America Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)
Figure 5: North America Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)
Figure 6: North America Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)
Figure 7: North America Anti-microbial/Anti-fungal Tests Market Value Share By Country (2017)
Figure 8: North America Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 9: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 10: U.S. Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 11: Canada Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 12: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027
Figure 13: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027
Figure 14: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027
Figure 15: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027
Figure 16: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027
Figure 17: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027
Figure 18: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027
Figure 19: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027
Figure 20: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027
Figure 21: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027
Figure 22: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027
Figure 23: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027
Figure 24: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027
Figure 25: North America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027
Figure 26: North America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027
Figure 27: North America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027
Figure 28: North America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027
Figure 29: North America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Country, 2017–2027
Figure 30: Latin America Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)
Figure 31: Latin America Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)
Figure 32: Latin America Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)
Figure 33: Latin America Anti-microbial/Anti-fungal Tests Market Value Share By Country (2017)
Figure 34: Latin America Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 35: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 36: Brazil Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 37: Mexico Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 38: Rest of Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 39: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027
Figure 40: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027
Figure 41: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027
Figure 42: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027
Figure 43: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027
Figure 44: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027
Figure 45: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027
Figure 46: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027
Figure 47: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027
Figure 48: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027
Figure 49: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027
Figure 50: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027
Figure 51: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027
Figure 52: Latin America Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027
Figure 53: Latin America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027
Figure 54: Latin America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027
Figure 55: Latin America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027
Figure 56: Latin America Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Country, 2017–2027
Figure 57: Western Europe Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)
Figure 58: Western Europe Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)
Figure 59: Western Europe Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)
Figure 60: Western Europe Anti-microbial/Anti-fungal Tests Market Value Share By Country (2017)
Figure 61: Western Europe Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 62: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 63: Germany Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 64: United Kingdom Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 65: France Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 66: Italy Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 67: Spain Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 68: Nordic Region Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 69: Rest of Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 70: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027
Figure 71: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027
Figure 72: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027
Figure 73: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027
Figure 74: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027
Figure 75: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027
Figure 76: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027
Figure 77: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027
Figure 78: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027
Figure 79: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027
Figure 80: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027
Figure 81: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027
Figure 82: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027
Figure 83: Western Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027
Figure 84: Western Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027
Figure 85: Western Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027
Figure 86: Western Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027
Figure 87: Western Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Country, 2017–2027
Figure 88: Eastern Europe Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)
Figure 89: Eastern Europe Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)
Figure 90: Eastern Europe Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)
Figure 91: Eastern Europe Anti-microbial/Anti-fungal Tests Market Value Share By Country (2017)
Figure 92: Eastern Europe Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 93: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 94: Russia Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 95: Poland Region Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 96: Rest of Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 97: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027
Figure 98: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027
Figure 99: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027
Figure 100: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027
Figure 101: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027
Figure 102: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027
Figure 103: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027
Figure 104: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027
Figure 105: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027
Figure 106: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027
Figure 107: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027
Figure 108: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027
Figure 109: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027
Figure 110: Eastern Europe Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027
Figure 111: Eastern Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027
Figure 112: Eastern Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027
Figure 113: Eastern Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027
Figure 114: Eastern Europe Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Country, 2017–2027
Figure 115: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)
Figure 116: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)
Figure 117: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)
Figure 118: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Value Share By Country (2017)
Figure 119: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 120: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 121: China Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 122: India Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 123: Australia & New Zealand Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 124: ASEAN Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 125: Rest of Asia Pacific Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 126: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027
Figure 127: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027
Figure 128: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027
Figure 129: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027
Figure 130: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027
Figure 131: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027
Figure 132: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027
Figure 133: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027
Figure 134: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027
Figure 135: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027
Figure 136: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027
Figure 137: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027
Figure 138: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027
Figure 139: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027
Figure 140: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027
Figure 141: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027
Figure 142: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027
Figure 143: Asia Pacific excluding Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Country, 2017–2027
Figure 144: Japan Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)
Figure 145: Japan Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)
Figure 146: Japan Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)
Figure 147: Japan Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 148: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 149: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027
Figure 150: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027
Figure 151: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027
Figure 152: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027
Figure 153: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027
Figure 154: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027
Figure 155: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027
Figure 156: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027
Figure 157: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027
Figure 158: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027
Figure 159: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027
Figure 160: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027
Figure 161: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027
Figure 162: Japan Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027
Figure 163: Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027
Figure 164: Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027
Figure 165: Japan Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027
Figure 166: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Value Share By Test Type (2017)
Figure 167: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Value Share By Infection Type (2017)
Figure 168: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Value Share By End User (2017)
Figure 169: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Value Share By Country (2017)
Figure 170: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 171: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 172: GCC Countries Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 173: South Africa Region Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 174: Rest of Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027
Figure 175: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Molecular Based Tests, 2012–2027
Figure 176: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Phenotypic Resistance Tests, 2012–2027
Figure 177: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Complex Test Panels, 2012–2027
Figure 178: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Mass Spectrometry , 2012–2027
Figure 179: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Rapid Diagnostic Tests, 2012–2027
Figure 180: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Antimicrobial Resistance, 2012–2027
Figure 181: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Microbial Infection, 2012–2027
Figure 182: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Anti-fungal Resistance , 2012–2027
Figure 183: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Fungal Infection, 2012–2027
Figure 184: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospitals, 2012–2027
Figure 185: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centers, 2012–2027
Figure 186: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Clinics, 2012–2027
Figure 187: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Community Health Centers, 2012–2027
Figure 188: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Size (US$ Mn) & Y-o-Y Growth (%) By Reference Laboratories, 2012–2027
Figure 189: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027
Figure 190: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027
Figure 191: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027
Figure 192: Middle East & Africa Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Country, 2017–2027
Figure 193: Global Anti-microbial/Anti-fungal Tests Market Y-o-Y Growth (%) 2017–2027, By Region
Figure 194: Global Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Region, 2017–2027
Figure 195: Global Anti-microbial/Anti-fungal Tests Market Y-o-Y Growth (%) 2017–2027, By Test Type
Figure 196: Global Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Test Type, 2017–2027
Figure 197: Global Anti-microbial/Anti-fungal Tests Market Y-o-Y Growth (%) 2017–2027, By Infection Type
Figure 198: Global Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By Infection Type, 2017–2027
Figure 199: Global Anti-microbial/Anti-fungal Tests Market Y-o-Y Growth (%) 2017–2027, By End User
Figure 200: Global Anti-microbial/Anti-fungal Tests Market Attractiveness Analysis By End User, 2017–2027
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
